GlassScriptPhysician profile
Andrew Luxhoj
NPI 1801274535
$22,460.31
in general payments reported to CMS, 2019-2025
19 companies · $1,095 in 2025
The $1,095 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $144 · 2021: $3,988 · 2022: $9,179 · 2023: $5,541 · 2024: $1,690 · 2025: $1,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,798 · Travel and Lodging: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,798.16 |
| Travel and Lodging | $528.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $10,724.93 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $3,284.80 | 2022-2025 | Impella |
| Abbott Laboratories | $3,240.80 | 2019-2025 | Amplatzer Amulet, Mitraclip, Xience Skypoint |
| Boston Scientific Corporation | $1,697.21 | 2019-2023 | Avvigo Guidance System, Ekosonic, Comet |
| Shockwave Medical, INC | $1,160.47 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $929.42 | 2021-2024 | Corevalve Evolut R, Symplicity G3 |
| Philips North America LLC | $285.97 | 2021-2024 | (5091) Amb Mon & Diag Und |
| Inari Medical, INC. | $212.06 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Teleflex LLC | $145.73 | 2022 | |
| Medtronic Vascular, INC. | $144.40 | 2020 | |
| Heartflow, INC. | $130.79 | 2022 | |
| Amgen INC. | $119.36 | 2021 | |
| Pfizer INC. | $117.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $96.44 | 2023-2025 | Fasenra, Breztri |
| Kestra Medical Technology Services, INC. | $74.47 | 2025 | Assure Wcd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $36.17 | 2024-2025 | |
| Becton, Dickinson and Company | $26.62 | 2023 | Ultrascore |
| Verona Pharma, INC. | $19.14 | 2025 | Ohtuvayre |
| Irhythm Technologies, INC. | $14.13 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Luxhoj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.